Inhibition of HLA-DM mediated MHC class II peptide loading by HLA-DO promotes self tolerance

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Denzin, Lisa K ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Antigen presentation; Autoimmunity; Diabetes; Germinal center reaction; HLA DM; HLA DO; MHC class II; Non obese diabetic

Indexed keywords

HLA DM ANTIGEN; HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; ENDOSOME; GERMINAL CENTER; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LEUKEMIA; LYMPHOMA; LYSOSOME; NONHUMAN; PROTEIN BINDING; SHORT SURVEY; SOMATIC HYPERMUTATION;

EID: 84892165022     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00465     Document Type: Short Survey

References (33)

1. Mathis D, Benoist C. Back to central tolerance. Immunity (2004) 20:509-16. doi:10.1016/S1074-7613(04)00111-6
2. Karlsson L. DM and DO shape the repertoire of peptide-MHC-class-II complexes. Curr Opin Immunol (2005) 17:65-70. doi:10.1016/j.coi.2004.11.003
3. Berger AC, Roche PA. MHC class II transport at a glance. J Cell Sci (2009) 122:1-4. doi:10.1242/jcs.035089
4. Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol (2013) 31:443-73. doi:10.1146/annurev-immunol-032712-095910
5. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 360:474-7. doi:10.1038/360474a0
6. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (1995) 378:457-62. doi:10.1038/378457a0
7. Jensen PE, Weber DA, Thayer WP, Chen X, Dao CT. HLA-DM and the MHC class II antigen presentation pathway. Immunol Res (1999) 20:195-205. doi:10.1007/BF02790403
8. Pos W, Sethi DK, Wucherpfennig KW. Mechanisms of peptide repertoire selection by HLA-DM. Trends Immunol (2013) 34:495-501. doi:10.1016/j.it.2013.06.002
9. Painter CA, Stern LJ. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol Rev (2012) 250:144-57. doi:10.1111/imr.12003
10. Pos W, Sethi DK, Call MJ, Schulze MS, Anders AK, Pyrdol J, et al. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell (2012) 151:1557-68. doi:10.1016/j.cell.2012.11.025
11. Alfonso C, Karlsson L. Nonclassical MHC class II molecules. Annu Rev Immunol (2000) 18:113-42. doi:10.1146/annurev.immunol.18.1.113
12. Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J (1996) 15:4817-24.
13. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science (1997) 278:106-9. doi:10.1126/science.278.5335.106
14. van Ham SM, Tjin EP, Lillemeier BF, Gruneberg U, van Meijgaarden KE, Pastoors L, et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol (1997) 7:950-7. doi:10.1016/S0960-9822(06)00414-3
15. Denzin LK, Fallas JL, Prendes M, Yi W. Right place, right time, right peptide: DO keeps DM focused. Immunol Rev (2005) 207:279-92. doi:10.1111/j.0105-2896.2005.00302.x
16. Chen X, Laur O, Kambayashi T, Li S, Bray RA, Weber DA, et al. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med (2002) 195:1053-62. doi:10.1084/jem.20012066
17. Glazier KS, Hake SB, Tobin HM, Chadburn A, Schattner EJ, Denzin LK. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J Exp Med (2002) 195:1063-9. doi:10.1084/jem.20012059
18. Chen X, Reed-Loisel LM, Karlsson L, Jensen PE. H2-O expression in primary dendritic cells. J Immunol (2006) 176:3548-56.
19. Hornell TM, Burster T, Jahnsen FL, Pashine A, Ochoa MT, Harding JJ, et al. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol (2006) 176:3536-47.
20. Fallas JL, Yi W, Draghi NA, O'Rourke HM, Denzin LK. Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function. J Immunol (2007) 178:1488-97.
21. Porter GW, Yi W, Denzin LK. TLR agonists downregulate H2-O in CD8alpha-dendritic cells. J Immunol (2011) 187:4151-60. doi:10.4049/jimmunol.1003137
22. Guce AI, Mortimer SE, Yoon T, Painter CA, Jiang W, Mellins ED, et al. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol (2012) 20:90-8. doi:10.1038/nsmb.2460
23. Yoon T, Macmillan H, Mortimer SE, Jiang W, Rinderknecht CH, Stern LJ, et al. Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis. Proc Natl Acad Sci U S A (2012) 109:11276-81. doi:10.1073/pnas.1113966109
24. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, et al. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J (1998) 17:2971-81. doi:10.1093/emboj/17.11.2971
25. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, et al. Altered antigen presentation in mice lacking H2-O. Immunity (1998) 8:233-43. doi:10.1016/S1074-7613(00)80475-6
26. Perraudeau M, Taylor PR, Stauss HJ, Lindstedt R, Bygrave AE, Pappin DJ, et al. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol (2000) 30:2871-80. doi:10.1002/1521-4141(200010)30:10<2871::AID-IMMU2871>3.0.CO;2-B
27. Draghi NA, Denzin LK. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc Natl Acad Sci U S A (2010) 107:16607-12. doi:10.1073/pnas.1004664107
28. McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol (2009) 21:266-73. doi:10.1016/j.coi.2009.05.010
29. Gu Y, Jensen PE, Chen X. Immunodeficiency and autoimmunity in H2-O-deficient mice. J Immunol (2012) 190:126-37. doi:10.4049/jimmunol.1200993
30. Gondre-Lewis TA, Moquin AE, Drake JR. Prolonged antigen persistence within nonterminal late endocytic compartments of antigen-specific B lymphocytes. J Immunol (2001) 166:6657-64.
31. Fallas JL, Tobin HM, Lou O, Guo D, Sant'Angelo DB, Denzin LK. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J Immunol (2004) 173:1549-60.
32. Yi W, Seth NP, Martillotti T, Wucherpfennig KW, Sant'Angelo DB, Denzin LK. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest (2010) 120:1324-36. doi:10.1172/JCI40220
33. Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 23:447-85. doi:10.1146/annurev.immunol.23.021704.115643